ClinicalTrialsFinder

Pituitary Stalk Interruption Syndrome Clinical Trials in Hull

1 recruitingHull, United Kingdom

Showing 1–1 of 1 trials

Recruiting
Phase 3

A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756)

Hypothalamic ObesityMultiple Pituitary Hormone Deficiency Genetic FormSepto-Optic Dysplasia+3 more
Rhythm Pharmaceuticals, Inc.39 enrolled11 locationsNCT06760546